Financial Gravity Companies’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.9K Buy
+1,035
New +$27.1K ﹤0.01% 429
2025
Q2
$21.7K Buy
+897
New +$20.9K ﹤0.01% 441
2024
Q4
$19K Buy
715
+278
+64% +$7.54K ﹤0.01% 454
2024
Q3
$12.6K Buy
+437
New +$12.7K ﹤0.01% 319
2018
Q4
$314K Buy
+7,721
New +$321K 0.29% 60
2018
Q1
$269K Buy
8,136
+144
+2% +$4.95K 0.28% 62
2017
Q4
$281K Buy
+7,992
New +$273K 0.32% 56

Other funds holding PFE

Financial Gravity Companies's PFE Position: Q2 2026 in Review

Financial Gravity Companies opened a new position in Pfizer (PFE) in Q2 2026: 1,035 shares worth $24.9K. The stake represents ﹤0.01% of the portfolio and ranks #429 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in PFE as recently as Q2 2025.

Financial Gravity Companies first reported a position in PFE in Q4 2017 and has held it in 7 quarters since. The position peaked at $314K in Q4 2018. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Financial Gravity Companies held 1,035 shares of Pfizer worth $24.9K as of Q2 2026.
  • Pfizer was a new Financial Gravity Companies position in Q2 2026.
  • Pfizer made up ﹤0.01% of Financial Gravity Companies's portfolio in Q2 2026, its #429 holding.
  • Financial Gravity Companies first reported a position in Pfizer in Q4 2017 and has held it in 7 quarters since.
  • Financial Gravity Companies's Pfizer position peaked at $314K in Q4 2018.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Financial Gravity Companies's 13F filing for Q2 2026, filed 5 Aug 2026.